Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis.

Autor: Mostafa S; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Shabana H; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Khalil F; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Mancy IME; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Zedan HA; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Elmoursi A; College of Medicine, University of Kentucky, Lexington, KY, USA., Ramadan IG; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Mohamed SED; Department of Internal Medicine, Al-Azhar University, Damietta, Egypt., Kassem A; Department of Internal Medicine, Al-Azhar University, Cairo, Egypt., Kamel IS; Fayoum University Hospital, Fayoum, Egypt. shawky201920@gmail.com.
Jazyk: angličtina
Zdroj: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension [High Blood Press Cardiovasc Prev] 2022 Nov; Vol. 29 (6), pp. 565-576. Date of Electronic Publication: 2022 Oct 26.
DOI: 10.1007/s40292-022-00544-3
Abstrakt: Introduction: Hypertension represent the commonest cause of death in 2017. Hypertension is classified into two types which are primary or essential hypertension and secondary hypertension. The perindopril-amlodipine combination showed a significant effect in reduction of the elevated BP and the cardiovascular complications.
Aim: To evaluate the efficacy and safety of a fixed-dose single-pill combination of perindopril-amlodipine in hypertensive patients.
Methods: We searched PubMed, Medline, SCOPUS, and Web of Science for relevant clinical trials. Quality appraisal was evaluated according to GRADE and we assessed the risk of bias using Cochrane's risk of bias tool. We included the following outcomes: systolic blood pressure, diastolic blood pressure, pulse pressure, mean blood pressure, heart rate, cough, dizziness, headache, and peripheral edema. We performed the analysis of homogeneous data under the fixed-effects model, while analysis of heterogeneous data was analyzed under the random-effects model. We conducted a meta-regression according to the dose.
Results: We included ten clinical trials. The pooled analysis showed that there was a significant reduction of the systolic blood pressure, diastolic blood pressure, pulse plessure, mean blood pressure, and heart rate after the the perindopril-amlodipine combination (MD = 18.96 [14.32, 23.60], P < 0.0001), (MD = 11.90 [8.45, 15.35], P < 0.0001), (MD = 8.44 [6.91, 9.97], P = 0.0001), (MD = 13.07 [5.86, 20.29], P = 0.0004), and (MD = 2.93 [0.89, 4.96], P = 0.005), respectively. The results of the meta-regression revealed that the efficacy is increased by increasing the dose (P < 0.001) CONCLUSION: The use of the perindopril-amlodipine combination had a significant effect on the reduction of SBP, DBP, mean blood pressure, pulse pressure, and HR.
(© 2022. Italian Society of Hypertension.)
Databáze: MEDLINE
Externí odkaz: